The oncogenic potential of polyomavirus in newborn rats could not be expressed by a genome encoding only the middle T antigen but required the presence of one of the other two viral early genes, small T or large T. The tumorigenicity defect could also be complemented by other viral or cellular genes that are known to be implicated in immortalization and establishment functions. The simian virus 40(cT)-3 mutant (R. E. Lanford and J. S. Butel, Cell 37:801-813, 1984), which fails to localize to the nucleus, has the capacity to complement polyomavirus middle T in tumorigenesis and to inmmortalize primary rat embryo fibroblasts when it was cotransfected in the presence of pSV2-neo. Our data suggested that under the conditions of DNA-mediated tumor induction and cotransfection with a dominant selection marker, the cellular alterations achieved by nonnuclear oncogenes such as polyomavirus small T and simian virus 40(cT)-3 were sufficient to complement polyomavirus middle T in transformation and tumorigenesis.
A challenging problem in the study of carcinogenesis is to determine how oncogenes transform cells and how their various modes of action can be interrelated. Many of the oncogenes identified to date can be grouped into functional classes on the basis of their effects on cellular phenotype, which suggests that there is only a small number of action mechanisms of the oncogene-encoded proteins (see reference 26 for a review). Some of these proteins mediate distinct and perhaps cooperative transformation-related functions that appear to correlate with their particular localization within the cell (13, 21) . In the cytoplasm, they may regulate levels of critical second messenger molecules, whereas in the nucleus they probably modulate the activity of the transcriptional machinery of the cell (26) . The requirement for two separate viral oncogenes with distinct functions can be illustrated by polyomavirus-mediated transformation. Polyomavirus encodes three different early proteins: the large, middle, and small T antigens (25) . The large T antigen is localized in the nucleus, whereas the middle T antigen is found on the cell surface (11) . The middle T antigen is capable of transforming established cell lines by itself but requires the presence of either small T or large T to transform primary cells in vitro and to induce tumors in newborn rats (2, 4) . This suggests that transformation by polyomavirus requires the cooperation of two distinct functions: one provided by the membrane-bound middle T antigen, the transforming protein, and the other by the nuclear T antigen or any other nuclear function implicated in immortalization or establishment.
In this work we attempted to complement polyomavirus middle T antigen with the simian virus 40 (SV40) cT mutant (15) . Because of a single amino acid change (Lys-128 --Asn) which interrupts a stretch of five positively charged amino acids, the mutant large T antigen is not transported to the nucleus. Transformation of established cell lines by the cT mutant is not significantly reduced under normal culture conditions, but transformation of primary cells does not occur in the absence of detectable levels of nuclear T antigen * Corresponding author. (16) . Our results show that, although the mutant large T antigen is not transported to the nucleus, it can efficiently complement polyomavirus middle T antigen in the induction of tumors in vivo and immortalize primary rat embryo fibroblasts in vitro.
MATERIALS AND METHODS
Plasmids. pSV1 (Fig. 1) carries the SV40 early region in the BamHI site of pBR322 and encodes both large and small T antigens. pSV2 (Fig. 1 ) encodes the SV40 large T antigen only. The sequences coding for large T antigen were provided by deletion mutant A2005. Because of a deletion between 0.54 and 0.59 map units, this mutant does not produce the small T antigen (22) . pBSV(cT)-3 ( Fig. 1) is an intact copy of the SV40(cT)-3 genome cloned into pBR322 at the BamHI site (15) . SV40(cT)-3 has a point mutation at nucleotide 4434 that abolishes the transport of T antigen to the nucleus (15) . pSV2cT-3 is a recombinant encoding only SV40(cT)-3 large T antigen. pMT3 ( Fig. 1) is a recombinant which expresses only the polyomavirus middle T antigen (2) . pMSV1 ( Fig. 1) is a plasmid encoding both polyomavirus middle T antigen and the SV40 early proteins. pMSV2 is a similar construct encoding both middle T and the SV40 large T antigens. pMSVcT-3 encodes both middle T antigen and the SV40(cT)-3 genome. pMSV2cT-3 encodes both middle T antigen and the large T antigen from the cT-3 mutant. pSV2-neo is a plasmid which expresses neo, a dominant selection marker (23) .
Cells, transfections, and growth assays. Primary Fischer rat embryo fibroblasts were transfected in the presence of pSV2-neo by the calcium phosphate-DNA coprecipitation procedure as previously described (1) . Cells were grown in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum. The DNA to be transfected (8 ,ug) (22) . pBSV(cT)-3 carries the SV40(cT)-3 genome. The position of the cT mutation is indicated by an arrow. To inactivate the small-T-antigen coding region in pBSV(cT)-3, the plasmid was modified by filling the gaps at the TaqI site (SV40 nucleotide 4739). Because the TaqI site is located in the large T intron, addition of two nucleotides in this site has no effect on the structure of the large T antigen. The cT mutant encoding only the large T antigen was designated pSV2cT-3. pMSV1 is a plasmid encoding both polyomavirus middle T (pmt) and the SV40 T antigens. The SV40 genome was cleaved by BamHI (SV40 nucleotide 2533) and inserted into pMT3, the middle T clone (polyomavirus nucleotide 4632). B, BamHI; T, TaqI; H, Hindlll; ori, origin. lmJ, Exons. newborn rats, we inoculated 2 ,ug of DNA into the necks of 1-day-old Fischer rats and observed the animals for tumor development over a 4-month period. The plasmid pPB21, carrying the wild-type polyomavirus genome, induced tumors in about half of the rats injected ( Table 1) . The plasmid pMT3, carrying the middle T gene alone, was completely inactive. This shows that functions other than those expressed by the polyomavirus middle T antigen are required for tumor induction in newborn rats. In a previous study we found that the tumorigenicity defect of middle T antigen could be complemented by either small T or large T antigen (4) . The role of small T antigen in transformation is still poorly understood. However, several studies have implicated large T antigen in immortalization and establishmelit (6, 20) . Thus, one could expect other immortalizing genes of viral as well as cellular origin to complement polyomavirus middle T in the tumorigenicity assay. Middle T was indeed complemented (Table 1) , although with low efficiencies, by SV40 large T (P = 0.01), adenovirus early region 1A (P -0.15), and the myc oncogene (P -0.05). When inoculated separately into newborn rats, none of the plasmids carrying the establishment genes gave rise to tumors (data not shown). Furthermore, we observed virtually the same results when polyomavirus middle T and the establishment genes were coinjected as separate linear plasmids or linked in the form of a hybrid plasmid (data not shown). The recombinant pMSV2-b, encoding the N-terminal fragment of large T antigen, was also active, although at a very low efficiency.
To determine the properties of the SV40 large T mutant that fails to localize to the nucleus, we used the PARA cT 10 days in the selective medium, and 2 to 3 weeks later independent colonies were picked, transferred to 15-mm Linbro microplates, and passaged at least once in medium containing 400 ,ug of G418 per ml. Most of the cells that senesced did not sustain more than one or two divisions after passage 1. Some cell lines senesced after passage 3 or occasionally after passage 4. However, once cell lines had been passaged five times, they could be considered immortalized. Of 217 lines that reached 5 passages, all could be brought to 10 passages within weeks. Twenty of these lines were picked randomly, and all could be brought to 30 passages. The cell lines that were either immortalized or oncogenically transformed were subcultured at a 1:5 dilution each time they reached confluence and were maintained in G418-free medium. Immortalization efficiencies were evaluated by counting the percentage of G418-resistant colonies sustaining five or more passages 7 to 8 weeks after the first transfer.
In vivo tumorigenesis. Recombinant DNAs were injected subcutaneously (2 ,ug of linear DNA in 50 of phosphatebuffered saline) into the necks of 1-day-old Fischer rats. The animals were examined regularly for tumor development during a 4-month period. Tumor tissues were propagated in culture as described previously (2) . Statistical analyses of the results were performed with the x2 test.
RESULTS
In vivo tumorigenesis. Tumor induction by injecting DNA into newborn rodents provides an in vivo equivalent to a transformation assay but appears to be a more stringent and rigorous criterion of oncogenic transformation (5) . To determine the ability of recombinant plasmids to induce tumors in (Table 1 ). The genome used in this experiment, pBSV(cT)-3, is an intact genome capable of encoding the large T as well as the small T antigen. In view of the ability of the polyomavirus small T antigen to complement middle T in tumorigenesis, we suspected that the activity of the SV40(cT)-3 genome could be due to the presence of the small T antigen. To inactivate the small-Tantigen-coding region, the structure of pBSV(cT)-3 was modified by filling the gaps at the TaqI site at nucleotide 4739 (Fig. 1) . Because the TaqI site is located in the large-Tantigen intron, the addition of two nucleotides in this site had no effect on the structure of the large T antigen but produced a frameshift in the small-T-antigen-coding sequence after Phe-141 that resulted in a termination signal 23 codons downstream. Surprisingly, inactivation of the small Tantigen-coding sequence did not abolish the activity of the SV40(cT)-3 mutant (Table 1 ). pMSV2cT-3 was less active than pMBSVcT-3 (P 0.09), the construct encoding both large T and small T antigens, but so was pMSV2, the plasmid encoding the wild-type SV40 large T antigen (P 0.06).
These results indicated that the SV40 small T antigen contributed to the tumorigenic potential of both pMSV1 and pMBSVcT-3. They also showed that the cT mutation did not affect significantly the ability of the SV40 large T protein to complement polyomavirus middle T in tumorigenesis.
Viral proteins synthesized in tumor cells. In a previous study we showed that the tumors obtained by injecting middle T-producing plasmids into newborn rats expressed, in addition to the middle T antigen, the polypeptides encoded by the cooperating gene (e.g., polyomavirus small T antigen, SV40 large T antigen, and adenovirus E1A) (3). Tumors induced by pMSV2 (polyomavirus middle T plus SV40 large T) produced the host-encoded protein designated p53 as well (3) . To further characterize these tumors, several representative cell lines were examined by immunofluorescence for the intracellular localization of T antigen. All of the cell lines derived from pMSV2-induced tumors displayed the typical nuclear T-antigen pattern of fluorescence (Fig. 2a) . By contrast, all of the tumor cell lines established by pMSVcT-3 displayed a bright cytoplasmic reaction for T antigen (Fig. 2b) . No faint or diffuse nuclear reaction could be observed in these cells. The association of SV40 large T antigen with the 53,000-molecular-weight nonviral tumor antigen is well documented (14, 17) . It was of interest to determine the intracellular distribution of p53 in tumor cell lines expressing the cytoplasmic large T antigen. The tumor cell lines were examined by immunofluorescence with the monoclonal antibody PAb421, which is specific for p53 (9) . The intracellular localization of p53 mimicked T-antigen distribution in all the tumor cell lines analyzed. The tumor cell lines obtained with pMSV2 had a nuclear reaction for p53, whereas the cell lines established with pMSVcT-3 exhibited a cytoplasmic reaction for p53 (data not shown). These results suggest that T- VOL. 59, 1986 antigen binding is the determining factor regulating the intracellular localization and accumulation of p53 in the tumor cells.
Immortalization of primary rat fibroblasts by SV40(cT)-3. The ability of pSV2cT-3 to complement polyomavirus middle T antigen in tumorigenesis raised the intriguing question of the effect of cytoplasmic large T antigen on the cell phenotype. To determine whether the mutant was able to immortalize primary cells, we transfected primary rat embryo fibroblasts with recombinant plasmids in the presence of pSV2-neo so that the transfected cultures could be placed under G418 selection. pSV2cT-3 immortalized as efficiently as did wild-type large T antigen (Table 2) . Although most of the cell lines established with these plasmids exhibited a flat, untransformed phenotype in cultures, some cell lines had a morphology characteristic of transformed cells. When these lines were assayed for growth in soft agar, only some of them were able to form colonies (data not shown). This suggests, in agreement with a previous study (4) , that as a result of neo selection most of the cell lines exhibited only a partially transformed phenotype. Several representative cell lines were examined by immunofluorescence for the intracellular localization of T antigen. All of the cell lines established by pSV2 displayed a nuclear reaction for T antigen (Fig. 2c) . Those established by pBSV(cT)-3 displayed the typical cytoplasmic T-antigen pattern of fluorescence (Fig. 2d) . Although these observations did not rule out the possibility that some cT antigen accumulated in the nucleus, they implied that the capacity of pBSV(cT)-3 to immortalize or transform primary rat embryo fibroblasts did not depend upon the ability of a subpopulation of the transfected cells to transport the mutant T antigen to the nucleus.
DISCUSSION
The oncogenic potential of polyomavirus in newborn rats cannot be expressed by a genome encoding only the middle T antigen but requires the presence of one of the other two viral early genes, small T or large T. A similar complementary function can also be exerted by other viral or cellular genes such as SV40 large T, adenovirus ElA, and the myc oncogene, i.e., genes that are known to be implicated in immortalization and establishment (6, 10, 18) . This is consistent with the widely held hypothesis which suggests that oncogenic transformation requires cooperation between establishment and transforming functions (13, 21) . The establishment of primary cells is usually associated with the expression of oncogenes whose products are localized in the nucleus, while malignant transformation of immortalized cells is associated with the expression of cytoplasmic oncogenes (26) . In this work we show that the cytoplasmic middle T oncogene can be complemented by the SV40(cT)-3 mutant which fails to localize to the nucleus. This result is reminiscent of the effect of polyomavirus small T antigen in tumorigenesis. Although small T antigen can cooperate with middle T antigen in the induction of tumors in newborn rats (2, 5) , the former cannot be implicated in establishment and immortalizing functions (19) (8, 16) . It has been proposed that transformation by SV40 is regulated by both nuclear and plasma membrane-associated T antigen (16 (4, 24) . Furthermore, cells bearing a single oncogene will not grow into a large mass unless the normal neighboring cells are removed by killing with a cytotoxic drug (7, 24) . It is interesting that like the cT mutant, bc1051 (a recombinant encoding both middle and small T antigens) does not transform primary cells in culture, yet both recombinants are biologically active when they are cotransfected with the neo marker (4; this work) or when they are assayed for in vivo tumorigenicity (2) . In our interpretation of these data we suggest that the response of a cell to an oncogene is strongly influenced by its environment. Under certain conditions, like those involved in cotransfection with a dominant selection marker or in DNA-mediated tumor induction, the cellular alterations achieved by nonnuclear oncogenes such as small T antigen and SV40(cT)-3 would be sufficient to complement polyomavirus middle T in transformation and tumorigenesis. Other studies have shown that some nuclear oncogenes can cooperate with one another (12) or even transform spontaneously immortalized cell lines (7) . Thus, it is conceivable that different oncogenes affect both immortalization and transformation to various degrees, depending on the assay system chosen. This suggests that, although classification of oncogenes into these two categories may be a useful operational definition, the two processes may be functionally related.
